MATERIAL SAFETY DATA SHEET N/A = Not Applicable (Prepared According To 29 CFR 1910.1200) Effective Date: 11/09 SECTION 1 - PRODUCT IDENTIFICATION Product Name: NPCA Hazardous Materials Chemical Family: N/A Identification System Generic Name: Disinfectant deoderant. Formula: N/A Suppliers Name: SUPERIOR CHEMICAL CORP. Flammability Suppliers Address: 1331 Wisconsin Avenue, Sheboygan, WI 53081 Reactivity Phone: 800-242-7694 Maximum Personal Protection EMERGENCY PHONE: 800-535-5053 SECTION 2 - HAZARDOUS INGREDIENTS CHEMICAL NAME PEL TWA-TLV STEL-TLV CARCINOGEN SECTION 3 - PHYSICAL DATA SECTION 4 - FIRE & EXPLOSION HAZARD DATA Boiling Range (˚F): 176°F Specific Gravity: 0.83 Flash Point (method used): 76°F (TCC) Vapor Pressure: 31 Vapor Density: Upper Explosive Limit: Not det. Not det. Lower Explosive Limit: % Volatile: N / A Extinguishing Media: Carbon dioxide, dry chemical or foam. Solubility in Water: Soluble Evaporation Rate: Special Fire Fighting Procedures: Wear full protective gear. Physical Description: Clear light yellow liquid with a floral scent. Unusual Fire & Explosion Hazards: Container may melt. VOC's: 4.940 lbs/gal. SECTION 5 - REACTIVITY DATA SECTION 6 - STORAGE & HANDLING INFO Stability: Stable Hazardous Polymerization: Will not occur. Precautions To Be Taken In Handling & Storage: Incompatibility (materials to avoid): Strong acids and oxidizers.
Keep out of reach of children. For use by trained personnel only. Keep container
closed during storage. For institutional and industrial use only. Hazardous Decomposition Products: Carbon dioxide. carbon monoxide SECTION 7 - HEALTH HAZARDS AND FIRST AID Effects of Overexposure First Aid Primary Route of Entry: Procedures: Skin: Prolonged exposure may cause irritation or dryness. Skin: Wash well with soap and water. Seek medical attention if Eyes: Irritant. Eyes: Irrigate for 15 minutes minimum. Seek medical attention. Inhalation: Dizziness, nausea, stomach ache and anorexia. Irritation Inhalation: Remove to fresh air. Ingestion: See first aid procedures. Ingestion: DO NOT INDUCE vomiting. Seek medical attention
Persons medicated with ANTABUSE will have adverse reactions
SECTION 8 - SPECIAL PROTECTION INFORMATION Respiratory Protection: Use in adequate ventilation. Ventilation: Provide local exhaust to keep TLV of Section 2 ingredients Protective Gloves: Yes. Other Protective Equipment:As needed to prevent direct contact. Eyes: Yes. SECTION 9 - SPILL OR LEAK PROCEDURES Steps to be taken in case material is released or spilled: Waste disposal method:
Mop up or otherwise absorb and hold material for disposal.
Any method in accordance with applicable laws.
Notice to reader: To the best of our knowledge, the information contained herein is accurate. However, neither the above named supplier nor any of its subsidiaries assumes anyliability whatsoever for the accuracy or completeness of the information contained herein. Final determination of suitability of any material is the sole responsibility of the user. All material may present unknown hazards and should be used with caution. Although certain hazards are described herein, we cannot guarantee that these are the only hazardsthat exist. **FOR FURTHER INFORMATION OR TO DOWNLOAD ADDITIONAL MSDS GO TO www.northwoodstm.com
** The health hazards given on this Material Safety Data Sheet apply to this product in its concentrated form (as supplied) and may differ significantly at use dilution. The signs and symptomsof overexposure apply only to negligence in handling or misuse of the concentrated product and not to the routine exposure of the diluted product underconditions or ordinary use.
A CASE OF THE CHRONIC FATIGUE SYNDROME IN A HORSE FROM USA EXAMINED IN DUBAI (UAE). Author: W. Tarello , DVM, C.P. 1644, 06129 PERUGIA 5 (ITALY) Accepted for Poster presentation at the THIRD INTERNATIONAL CLINICAL AND SCIENTIFIC MEETING: Chronic Fatigue Syndrome, a serious legitimate diagnosis. Sydney, 1-2 December 2001. ABSTRACT - A six-year old castrated male warm-blood horse with a two-year
Polyfarmacie Optimalisatie Methode (POM) De Polyfarmacie Optimalisatie Methode (POM) is een stappenplan dat gebruikt kan worden om op een gestructureerde wijze ingewikkelde polyfarmacie te optimaliseren. De eerste twee stappen van de POM kunnen door een daartoe aangewezen praktijkondersteuner uitgevoerd worden. De stappen 3 en 4 moeten door de (huis)arts uitgevoerd worden. Voor de stappen 5